Search

Milton Nelson Jr.

Examiner (ID: 8060, Phone: (571)272-6861 , Office: P/3636 )

Most Active Art Unit
3636
Art Unit(s)
3624, 3636, 3507, 2899
Total Applications
4348
Issued Applications
3635
Pending Applications
235
Abandoned Applications
521

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 16326812 [patent_doc_number] => 20200297777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-09-24 [patent_title] => METHODS OF TRANSDIFFERENTIATION AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/836967 [patent_app_country] => US [patent_app_date] => 2020-04-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 36058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16836967 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/836967
Methods of transdifferentiation and methods of use thereof Mar 31, 2020 Issued
Array ( [id] => 16345126 [patent_doc_number] => 20200309776 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-10-01 [patent_title] => HLA G-MODIFIED CELLS AND METHODS [patent_app_type] => utility [patent_app_number] => 16/832321 [patent_app_country] => US [patent_app_date] => 2020-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15438 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -21 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16832321 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/832321
HLA G-MODIFIED CELLS AND METHODS Mar 26, 2020 Abandoned
Array ( [id] => 17748303 [patent_doc_number] => 20220226506 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-07-21 [patent_title] => EXPRESSION CONSTRUCTS FOR THE GENETIC MODIFICATION OF CELLS [patent_app_type] => utility [patent_app_number] => 17/439921 [patent_app_country] => US [patent_app_date] => 2020-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14361 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17439921 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/439921
EXPRESSION CONSTRUCTS FOR THE GENETIC MODIFICATION OF CELLS Mar 16, 2020 Pending
Array ( [id] => 17664111 [patent_doc_number] => 11357787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-06-14 [patent_title] => Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent [patent_app_type] => utility [patent_app_number] => 17/431268 [patent_app_country] => US [patent_app_date] => 2020-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 10 [patent_no_of_words] => 13877 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17431268 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/431268
Method for selecting cells, method for producing nucleic acid, method for producing recombinant cells, method for producing target substance, method for producing pharmaceutical composition, and reagent Feb 16, 2020 Issued
Array ( [id] => 16013453 [patent_doc_number] => 20200181569 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-11 [patent_title] => EXPANDABLE CELL POPULATIONS FROM BRAIN BIOPSIES OF LIVING SUBJECTS [patent_app_type] => utility [patent_app_number] => 16/788037 [patent_app_country] => US [patent_app_date] => 2020-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11342 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788037 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/788037
EXPANDABLE CELL POPULATIONS FROM BRAIN BIOPSIES OF LIVING SUBJECTS Feb 10, 2020 Abandoned
Array ( [id] => 16188561 [patent_doc_number] => 20200229410 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-23 [patent_title] => GENETICALLY MODIFIED NON-HUMAN ANIMALS AND METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/782708 [patent_app_country] => US [patent_app_date] => 2020-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37875 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16782708 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/782708
Genetically modified non-human animals and methods of use thereof Feb 4, 2020 Issued
Array ( [id] => 16590580 [patent_doc_number] => 10899830 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-26 [patent_title] => Methods and compositions for delivering MRNA coded antibodies [patent_app_type] => utility [patent_app_number] => 16/752327 [patent_app_country] => US [patent_app_date] => 2020-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 17916 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16752327 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/752327
Methods and compositions for delivering MRNA coded antibodies Jan 23, 2020 Issued
Array ( [id] => 18301092 [patent_doc_number] => 11622978 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-04-11 [patent_title] => Immune cells defective for SUV39H1 [patent_app_type] => utility [patent_app_number] => 16/747198 [patent_app_country] => US [patent_app_date] => 2020-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18708 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16747198 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/747198
Immune cells defective for SUV39H1 Jan 19, 2020 Issued
Array ( [id] => 15899205 [patent_doc_number] => 20200149121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => METHOD FOR UTILIZING ENGINEERED DENDRITIC CELLS TO INDUCE GUT-HOMING REGULATORY T CELLS AND TREAT GUT INFLAMMATION [patent_app_type] => utility [patent_app_number] => 16/744296 [patent_app_country] => US [patent_app_date] => 2020-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16831 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16744296 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/744296
Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation Jan 15, 2020 Issued
Array ( [id] => 17312862 [patent_doc_number] => 20210401910 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME [patent_app_type] => utility [patent_app_number] => 16/733453 [patent_app_country] => US [patent_app_date] => 2020-01-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5419 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -9 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16733453 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/733453
EXPRESSION VECTOR, PHARMACEUTICAL COMPOSITION AND METHOD FOR PREPARING THE SAME Jan 2, 2020 Abandoned
Array ( [id] => 16748866 [patent_doc_number] => 20210100875 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-04-08 [patent_title] => RESTORATION OF VISUAL RESPONSES BY IN VIVO DELIVERY OF RHODOPSIN NUCLEIC ACIDS [patent_app_type] => utility [patent_app_number] => 16/700201 [patent_app_country] => US [patent_app_date] => 2019-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22778 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16700201 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/700201
Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids Dec 1, 2019 Issued
Array ( [id] => 20127940 [patent_doc_number] => 12370240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-07-29 [patent_title] => Methods and compositions for treating osteoarthritis [patent_app_type] => utility [patent_app_number] => 17/295588 [patent_app_country] => US [patent_app_date] => 2019-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18887 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17295588 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/295588
Methods and compositions for treating osteoarthritis Nov 25, 2019 Issued
Array ( [id] => 17412731 [patent_doc_number] => 20220047635 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-02-17 [patent_title] => METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY [patent_app_type] => utility [patent_app_number] => 17/309209 [patent_app_country] => US [patent_app_date] => 2019-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26546 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -42 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309209 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/309209
METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY Nov 21, 2019 Pending
Array ( [id] => 18027967 [patent_doc_number] => 11511129 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-11-29 [patent_title] => Photosensitive cardiac rhythm modulation systems [patent_app_type] => utility [patent_app_number] => 16/689178 [patent_app_country] => US [patent_app_date] => 2019-11-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 13090 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16689178 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/689178
Photosensitive cardiac rhythm modulation systems Nov 19, 2019 Issued
Array ( [id] => 15589707 [patent_doc_number] => 20200071388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => Immunoglobulin Variable Region Libraries [patent_app_type] => utility [patent_app_number] => 16/688666 [patent_app_country] => US [patent_app_date] => 2019-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8718 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -2 [patent_words_short_claim] => 194 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16688666 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/688666
Immunoglobulin Variable Region Libraries Nov 18, 2019 Abandoned
Array ( [id] => 16053241 [patent_doc_number] => 20200188475 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-18 [patent_title] => REAGENTS FOR INDUCING AN IMMUNE RESPONSE [patent_app_type] => utility [patent_app_number] => 16/683882 [patent_app_country] => US [patent_app_date] => 2019-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 39588 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -27 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16683882 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/683882
REAGENTS FOR INDUCING AN IMMUNE RESPONSE Nov 13, 2019 Abandoned
Array ( [id] => 17503510 [patent_doc_number] => 20220096612 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-03-31 [patent_title] => METHODS FOR INDUCING IMMUNE TOLERANCE [patent_app_type] => utility [patent_app_number] => 17/292923 [patent_app_country] => US [patent_app_date] => 2019-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27761 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292923 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292923
METHODS FOR INDUCING IMMUNE TOLERANCE Nov 11, 2019 Pending
Array ( [id] => 15895237 [patent_doc_number] => 20200147137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-05-14 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER [patent_app_type] => utility [patent_app_number] => 16/679127 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 32112 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -89 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16679127 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/679127
COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER Nov 7, 2019 Abandoned
Array ( [id] => 17533907 [patent_doc_number] => 20220112516 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-04-14 [patent_title] => GENE THERAPY EMPLOYING GENOME EDITING WITH SINGLE AAV VECTOR [patent_app_type] => utility [patent_app_number] => 17/292343 [patent_app_country] => US [patent_app_date] => 2019-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12081 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17292343 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/292343
GENE THERAPY EMPLOYING GENOME EDITING WITH SINGLE AAV VECTOR Nov 7, 2019 Abandoned
Array ( [id] => 17314901 [patent_doc_number] => 20210403949 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-12-30 [patent_title] => VECTOR SYSTEM FOR EXPRESSING REGULATORY RNA [patent_app_type] => utility [patent_app_number] => 17/289653 [patent_app_country] => US [patent_app_date] => 2019-11-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21661 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17289653 [rel_patent_id] =>[rel_patent_doc_number] =>)
17/289653
Vector system for expressing regulatory RNA Nov 4, 2019 Issued
Menu